Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release

Resham Chhabra, Andreas M. Grabrucker, Patrizia Veratti, Daniela Belletti, Tobias M. Boeckers, Maria Angela Vandelli, Flavio Forni, Giovanni Tosi, Barbara Ruozi

Research output: Contribution to journalArticlepeer-review

Abstract

Polymeric nanoparticles (NPs) offer a promising approach for therapeutic intracellular delivery of proteins, conventionally hampered by short half-lives, instability and immunogenicity. Remarkably, NPs uptake occurs via endocytic internalization leading to NPs content's release within lysosomes. To overcome lysosomal degradation and achieve NPs and/or loaded proteins release into cytosol, we propose the formulation of hybrid NPs by adding 1,2-dioleoyl-sn- glycero-3-phosphoethanolamine (DOPE) as pH sensitive component in the formulation of poly-lactide-co-glycolide (PLGA) NPs. Hybrid NPs, featured by different DOPE/PLGA ratios, were characterized in terms of structure, stability and lipid organization within the polymeric matrix. Experiments on NIH cells and rat primary neuronal cultures highlighted the safety profile of hybrid NPs. Moreover, after internalization, NPs are able to transiently destabilize the integrity of lysosomes in which they are taken up, speeding their escape and favoring cytoplasmatic localization. Thus, these DOPE/PLGA-NPs configure themselves as promising carriers for intracellular protein delivery.

Original languageEnglish
Pages (from-to)349-357
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume471
Issue number1-2
DOIs
Publication statusPublished - 25 Aug 2014
Externally publishedYes

Keywords

  • DOPE
  • Drug delivery
  • Endo-lysosomes
  • Nanoparticles (NPs)
  • PLGA
  • Stability

Fingerprint

Dive into the research topics of 'Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release'. Together they form a unique fingerprint.

Cite this